<DOC>
	<DOC>NCT02238275</DOC>
	<brief_summary>Study to evaluate efficacy and tolerability of Micardis® plus under usual daily-practice prescribing-conditions</brief_summary>
	<brief_title>Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Adult (Age &gt;= 18 years) males and females for whom a medical antihypertensive therapy is indicated Age &lt; 18 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>